Down-regulation of hepatic AMP-activated protein kinase and up-regulation of CREB coactivator CRTC2 for gluconeogenesis under calorie-restricted conditions at a young age

Acta Medica Nagasakiensia

Volumn 55, Issue 2, 2011, Pages 85-92

  Trindade, Lucas Siqueira ^a   Park, Seong Joon ^a   Komatsu, Toshimitsu ^a   Yamaza, Haruyoshi ^a   Hayashi, Hiroko ^a   Mori, Ryoichi ^a   Chiba, Takuya ^a   Shimokawa, Isao ^a   Kuramoto, Kazunao ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

AMPK; Calorie restriction; CRCT2; CREB; Gluconeogenesis; mTOR

Indexed keywords

EID: 85024730059     PISSN: 00016055     EISSN: None     Source Type: Journal    
DOI: 10.11343/amn.55.85     Document Type: Article

References (26)

1. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 117: 5479-5487, 2004
2. Lim CT, Kola B, Korbonits M. AMPK as a mediator of hormonal signalling. J Mol Endocrinol 44: 87-97, 2010
3. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100: 328-341, 2007
4. McCarty MF. Chronic activation of AMP-activated kinase as a strategy for slowing aging. Med Hypotheses 63: 334-339, 2004
5. Apfeld J, O'Connor G, McDonagh T, DiStefano PS, Curtis R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 18: 3004-3009, 2004
6. Greer EL, Dowlatshahi D, Banko MR, et al. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol 17: 1646-1656, 2007
7. Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, Müller F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426: 620, 2003
8. Selman C, Tullet JMA, Wieser D, et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326: 140-144, 2009
9. To K, Yamaza H, Komatsu T, et al. Down-regulation of AMP-activated protein kinase by calorie restriction in rat liver. Exp Gerontol 42: 1063-1071, 2007
10. Gonzalez AA, Kumar R, Mulligan JD, Davis AJ, Weindruch R, Saupe KW. Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity. Am J Physiol Endocrinol Metabol 287: E1032-1037, 2004
11. Jiang W, Zhu Z, Thompson HJ. Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Res 68: 5492-5499, 2008
12. Koo SH, Flechner L, Qi L, et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437: 1109-1111, 2005
13. Baur JA, Pearson KJ, Price NL, Jamieson HA, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342, 2006
14. Park S, Komatsu T, Hayashi H, et al. Calorie restriction initiated at middle age improved glucose tolerance without affecting age-related impairments of insulin signaling in rat skeletal muscle. Exp Gerontol 41: 837-845, 2006
15. Park S, Komatsu T, Hayashi H, et al. Calorie restriction initiated at a young age activates the Akt/PKCξ/λ-Glut4 pathway in rat white adipose tissue in an insulin-independent manner. AGE 30: 293-302, 2008
16. Kudo N, Gillespie JG, Kung L, et al. Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1301: 67-75, 1996
17. Zhu M, Miura J, Lu LX, Bernier M, DeCabo R, Lane MA, Roth GS, Ingram DK. Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization. Exp Gerontol. 2004; 39: 1049-1059
18. Chiba T, Yamaza H, Komatsu T, et al. Pituitary growth hormone suppression reduces resistin expression and enhances insulin effectiveness: relationship with caloric restriction. Exp Gerontol 43: 595-600, 2008
19. Yamaza H, Komatsu T, To K, et al. Involvement of insulin-like growth factor-1 in the effect of caloric restriction: regulation of plasma adiponectin and leptin. J Gerontol A Biol Sci Med Sci 62: 27-33, 2007
20. Polak P, Hall MN. mTOR and the control of whole body metabolism. Curr Opin Cell Biol 21: 209-218, 2009
21. Anisimov VN, Zabezhinski MA, Popovich IG, et al. Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice. Am J Pathol 176: 2092-2097, 2010
22. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9: 563-575, 2009
23. Yang J, Maika S, Craddock L, King JA, Liu ZM. Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice. Biochem Biophys Res Commun 370: 248-253, 2008
24. Shaw RJ, Lamia KA, Vasquez D, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310: 1642-1646, 2005
25. Anthony NM, Gaidhu MP, Ceddia RB. Regulation of visceral and subcutaneous adipocyte lipolysis by acute AICAR-induced AMPK activation. Obesity (Silver Spring) 17: 1312-1317, 2009
26. Garton AJ, Campbell DG, Carling D, Hardie DG, Colbran RJ, Yeaman SJ. Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. Eur J Biochem 179: 249-254, 1989